Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Beta Bionics Inc (BBNX)

Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance GlobeNewswire - Wed Jul 29, 3:02PM CDT

IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results...

BBNX : 18.08 (+4.33%)
Can Beta Bionics Prove New Patient Growth Still Matters More Than Revenue? Barchart - Tue Jul 28, 4:03PM CDT

Barchart Research What to Expect from BBNX Earnings BBNX Generated July 28, 2026 Current Price $15.80 EPS Estimate $$-0.62 Consensus Rating Moderate Buy Average Move 11.34% Can Beta Bionics Prove New Patient...

BBNX : 18.08 (+4.33%)
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders PR Newswire - Wed Jul 1, 10:28AM CDT

SAN DIEGO , July 1, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation...

BBNX : 18.08 (+4.33%)
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026 GlobeNewswire - Wed Jul 1, 7:30AM CDT

IRVINE, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to...

BBNX : 18.08 (+4.33%)
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders PR Newswire - Mon Jun 22, 11:15AM CDT

SAN DIEGO , June 22, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation...

BBNX : 18.08 (+4.33%)
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX) Business Wire - Mon Jun 15, 9:25AM CDT

Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or...

BBNX : 18.08 (+4.33%)
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth PR Newswire - Fri Jun 12, 11:50AM CDT

SAN DIEGO , June 12, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation...

BBNX : 18.08 (+4.33%)
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel Business Wire - Wed Jun 3, 8:47AM CDT

Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors’ losses and...

BBNX : 18.08 (+4.33%)
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders PR Newswire - Tue Jun 2, 2:41PM CDT

SAN DIEGO , June 2, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP  is investigating Beta Bionics, Inc. (NASDAQ: BBNX) to determine whether certain Beta Bionics officers and directors...

BBNX : 18.08 (+4.33%)
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website GlobeNewswire - Tue Jun 2, 8:00AM CDT

IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that near real-time...

BBNX : 18.08 (+4.33%)

Barchart Exclusives

H&R Block Posted Strong Earnings and Boosted Its Dividend by Nearly 10%. What This Means for HRB Stock. Barchart - Thu Aug 13, 6:30PM CDT
H&R Block beat fiscal fourth-quarter estimates, raised its fiscal 2027 outlook, and increased its quarterly dividend by nearly 10% to $0.46 per share, sending the stock up about 16%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.